This is not the most recent version of this material.
For an updated version, please see the relevant topic page.
Prostate Cancer: Evidence Report
Evidence report on anti-androgen drugs for high risk prostate cancer. This report will serve as the basis for discussion during a public meeting of Midwest CEPAC in September 2018.View All Materials on this Topic or Go Back to View More Materials